Works about SODIUM cotransport systems


Results: 203
    1
    2
    3

    Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 344, doi. 10.1111/dom.13077
    By:
    • Persson, Frederik;
    • Nyström, Thomas;
    • Jørgensen, Marit E.;
    • Carstensen, Bendix;
    • Gulseth, Hanne L.;
    • Thuresson, Marcus;
    • Fenici, Peter;
    • Nathanson, David;
    • Eriksson, Jan W.;
    • Norhammar, Anna;
    • Bodegard, Johan;
    • Birkeland, Kåre I.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    44
    45
    46
    47
    48
    49
    50